Analysis of Outbreak and Global Impacts of the COVID-19

Corona viruses are a large family of viruses that are not only restricted to causing illness in humans but also affect animals such as camels, cattle, cats, and bats, thus affecting a large group of living species. The outbreak of Corona virus in late December 2019 (also known as COVID-19) raised major concerns when the outbreak started getting tremendous. While the first case was discovered in Wuhan, China, it did not take long for the disease to travel across the globe and infect every continent (except Antarctica), killing thousands of people. Since it has become a global concern, different countries have been working toward the treatment and generation of vaccine, leading to different speculations. While some argue that the vaccine may only be a few weeks away, others believe that it may take some time to create the vaccine. Given the increasing number of deaths, the COVID-19 has caused havoc worldwide and is a matter of serious concern. Thus, there is a need to study how the disease has been propagating across continents by numbers as well as by regions. This study incorporates a detailed description of how the COVID-19 outbreak started in China and managed to spread across the globe rapidly. We take into account the COVID-19 outbreak cases (confirmed, recovered, death) in order to make some observations regarding the pandemic. Given the detailed description of the outbreak, this study would be beneficial to certain industries that may be affected by the outbreak in order to take timely precautionary measures in the future. Further, the study lists some industries that have witnessed the impact of the COVID-19 outbreak on a global scale.

[1]  C. Macintyre Global spread of COVID-19 and pandemic potential , 2020 .

[2]  Alfonso J. Rodriguez-Morales,et al.  A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19) , 2020 .

[3]  L. Gostin,et al.  The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. , 2020, JAMA.

[4]  R. Fouchier,et al.  MERS: emergence of a novel human coronavirus , 2014, Current Opinion in Virology.

[5]  Po-Yu Liu,et al.  2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China , 2020, Journal of Microbiology, Immunology and Infection.

[6]  B. Mohanty,et al.  Epidemic size, duration and vaccine stockpiling following a large-scale attack with smallpox , 2019, Global Biosecurity.

[7]  J. Rocklöv,et al.  The reproductive number of COVID-19 is higher compared to SARS coronavirus , 2020, Journal of travel medicine.

[8]  A. Wilder-Smith,et al.  Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak , 2020, Journal of travel medicine.

[9]  R. Rappuoli,et al.  SARS — beginning to understand a new virus , 2003, Nature Reviews Microbiology.

[10]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[11]  S. Zhang,et al.  Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis , 2020, International Journal of Infectious Diseases.

[12]  C. Macintyre On a knife's edge of a COVID-19 pandemic: is containment still possible? , 2020, Public health research & practice.

[13]  W. Ko,et al.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges , 2020, International Journal of Antimicrobial Agents.

[14]  Christl A. Donnelly,et al.  Report 2: Estimating the potential total number of novel Coronavirus cases in Wuhan City, China , 2020 .

[15]  G. Whittaker,et al.  A camel-derived MERS-CoV with a variant spike protein cleavage site and distinct fusion activation properties , 2016, Emerging Microbes & Infections.

[16]  M. Baguelin,et al.  Report 4: Severity of 2019-novel coronavirus (nCoV) , 2020 .

[17]  Syed Faraz Ahmed,et al.  Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies , 2020, Viruses.

[18]  Moritz U G Kraemer,et al.  Potential for global spread of a novel coronavirus from China , 2020, Journal of travel medicine.

[19]  Kun Chen,et al.  Characteristics of COVID-19 infection in Beijing , 2020, Journal of Infection.

[20]  C. Campèse,et al.  First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[21]  P. Daszak,et al.  Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin , 2018, Nature.

[22]  C. Akdis,et al.  Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.

[23]  E. Jung,et al.  Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study , 2015, BMC Medicine.

[24]  Youjun Feng,et al.  Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus , 2007, Comparative Immunology, Microbiology and Infectious Diseases.

[25]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[26]  Jessica T Davis,et al.  The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak , 2020, Science.

[27]  Heshui Shi,et al.  Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet Infectious Diseases.

[28]  Yunpeng Ji,et al.  Potential association between COVID-19 mortality and health-care resource availability , 2020, The Lancet Global Health.

[29]  L. Meyers,et al.  Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China , 2020, Emerging infectious diseases.

[30]  Matthew R. McKay,et al.  Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies , 2020, bioRxiv.

[31]  M. Fraser,et al.  Straining the System: Novel Coronavirus (COVID-19) and Preparedness for Concomitant Disasters. , 2020, American journal of public health.

[32]  Long Jiang Zhang,et al.  Coronavirus Disease 2019 (COVID-19): A Perspective from China , 2020, Radiology.

[33]  Heshui Shi,et al.  Severe Acute Respiratory Disease in a Huanan Seafood Market Worker: Images of an Early Casualty , 2020, Radiology. Cardiothoracic imaging.